Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Accelerating Parkinson's Disease drug development with federated learning approaches.

Khanna A. et al, (2024), NPJ Parkinsons Dis, 10

Defining an ageing-related pathology, disease or syndrome: International Consensus Statement.

Short E. et al, (2024), Geroscience

Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus Statement

Short E. et al, (2024)

Daily steps are a predictor of, but perhaps not a modifiable risk factor for Parkinson’s Disease: findings from the UK Biobank

Acquah A. et al, (2024)

Retinal morphological differences in atypical Parkinsonism: A cross-sectional analysis of the AlzEye cohort

Patel S. et al, (2024), Biomarkers in Neuropsychiatry, 10

Differential effects of bilateral hippocampal CA3 damage on the implicit learning and recognition of complex event sequences.

Miller TD. et al, (2024), Cogn Neurosci, 1 - 29

The oculomotor microcosm.

Antoniades CA., (2024), Brain Commun, 6

Eye movements in Parkinson's disease: from neurophysiological mechanisms to diagnostic tools

ANTONIADES C., (2023), Trends in Neurosciences

Using Smartphone Sensors for Ataxia Trials: Consensus Guidance by the Ataxia Global Initiative Working Group on Digital-Motor Biomarkers

ANTONIADES C., (2023), The Cerebellum: an international journal from neurosciences to clinical perspectives

Retinal Optical Coherence Tomography Features Associated With Incident and Prevalent Parkinson Disease.

Wagner SK. et al, (2023), Neurology, 101, e1581 - e1593

Identification of motor progression in Parkinson’s disease using wearable sensors and machine learning

Sotirakis C. et al, (2023), npj Parkinson's Disease, 9

Antiparkinsonian medication masks motor signal progression in de novo patients

Brzezicki MA. et al, (2023), Heliyon, 9, e16415 - e16415

Quantitative Oculomotor Assessment in Hereditary Ataxia: Systematic Review and Consensus by the Ataxia Global Initiative Working Group on Digital-motor Biomarkers

Garces P. et al, (2023), The Cerebellum

Quantitative Oculomotor Assessment in Hereditary Ataxia: Discriminatory Power, Correlation with Severity Measures, and Recommended Parameters for Specific Genotypes

Garces P. et al, (2023), The Cerebellum

Longitudinal monitoring of Progressive Supranuclear Palsy using Body-Worn movement sensors

ANTONIADES C. and FITZGERALD J., (2022), MDS

Oculomotor deficits in Parkinson's disease: Increasing sensitivity using multivariate approaches

Bredemeyer O. et al, (2022), Frontiers in Digital Health, 4

Deep Brain Stimulation and Levodopa Affect Gait Variability in Parkinson Disease Differently

Su ZH. et al, (2022), Neuromodulation: Technology at the Neural Interface

Art Exists Because the Viewer Exists How François Morellet’s Triple X Neonly Influences Postural Control and Subjective Aesthetic Appreciation

Ward LM. et al, (2022), Leonardo, 55, 48 - 50

Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study

Pereira MF. et al, (2022), BMJ Neurology Open, 4, e000214 - e000214

Parkinson's disease deficits in time perception to auditory as well as visual stimuli - A large online study.

Su ZH. et al, (2022), Front Neurosci, 16

Load More

Include forthcoming?